Pages that link to "Q48230349"

The following pages link to Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern (Q48230349):

Displaying 43 items.

• Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component (Q27654862) (← links)
• Role of Neuroprotein S-100B in the Diagnostic of Pediatric Mild Brain Injury. (Q31040365) (← links)
• CSF biomarkers for improved prognostic accuracy in acute CNS disease (Q33313220) (← links)
• Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review (Q33863821) (← links)
• Subarachnoid Hemorrhage Induces Gliosis and Increased Expression of the Pro-inflammatory Cytokine High Mobility Group Box 1 Protein (Q34769364) (← links)
• Kinetic modelling of serum S100b after traumatic brain injury. (Q36055674) (← links)
• Axonal damage and outcome in subarachnoid haemorrhage. (Q36142095) (← links)
• Myelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases (Q36270112) (← links)
• Serum Concentrations of S100B are not Affected by Cycling to Exhaustion With or Without Vibration (Q36657804) (← links)
• Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathology (Q36702235) (← links)
• Reliability of S100B in predicting severity of central nervous system injury (Q36830747) (← links)
• The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications (Q36873758) (← links)
• S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury (Q36933470) (← links)
• A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury (Q37590627) (← links)
• Addressing the needs of traumatic brain injury with clinical proteomics (Q37685775) (← links)
• Neurofilament heavy chain as a marker of neuroaxonal pathology and prognosis in acute encephalitis (Q39219451) (← links)
• Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer's disease. (Q39428145) (← links)
• Functional and proteomic analysis of serum and cerebrospinal fluid derived from patients with traumatic brain injury: a pilot study (Q39663086) (← links)
• Correlation of cerebral Near-infrared spectroscopy (cNIRS) and neurological markers in critically ill children (Q40075518) (← links)
• Glial S100B is elevated in serum across the spectrum of West Nile virus infection (Q40287128) (← links)
• Elevated levels of cerebrospinal fluid S100B are associated with brain injury and unfavorable outcomes in children with central nervous system infections (Q40854865) (← links)
• Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy. (Q40895548) (← links)
• Blood-brain barrier dysfunction following traumatic brain injury: correlation of K(trans) (DCE-MRI) and SUVR (99mTc-DTPA SPECT) but not serum S100B. (Q41272604) (← links)
• The Passage of S100B from Brain to Blood Is Not Specifically Related to the Blood-Brain Barrier Integrity (Q42008737) (← links)
• High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types (Q42250827) (← links)
• Genome-wide association and interaction studies of CSF T-tau/Aβ42 ratio in ADNI cohort (Q47993703) (← links)
• Topical application of the hematostatic agent Surgiflo® could attenuate brain injury in experimental TBI mice. (Q48349061) (← links)
• Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males (Q48399631) (← links)
• Elevated concentrations of hypoxia-inducible factor-1α in patients with fracture and concomitant traumatic brain injury (Q48443124) (← links)
• Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity (Q48488968) (← links)
• Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. (Q48522853) (← links)
• S100B protein activates a RAGE-dependent autocrine loop in astrocytes: implications for its role in the propagation of reactive gliosis (Q48718934) (← links)
• Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections (Q48735500) (← links)
• Amniotic fluid brain-specific proteins are biomarkers for spinal cord injury in experimental myelomeningocele (Q48763817) (← links)
• Reference ranges for neuroprotein S-100B: from infants to adolescents (Q48930135) (← links)
• Hyperacute detection of neurofilament heavy chain in serum following stroke: a transient sign (Q48986769) (← links)
• Evaluation of an alternative S100b assay for use in cardiac surgery: relationship with microemboli and neuropsychological outcome (Q50650998) (← links)
• Longitudinal serum S100β and brain aging in the Lothian Birth Cohort 1936 (Q56992670) (← links)
• Assessment of the advantage of the serum S100B protein biomonitoring in the management of paediatric mild traumatic brain injury-PROS100B: protocol of a multicentre unblinded stepped wedge cluster randomised trial. (Q64889399) (← links)
• Multifarious diagnostic possibilities of the S100 protein family: predominantly in pediatrics and neonatology (Q88956893) (← links)
• Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study (Q89513250) (← links)
• Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH) (Q90245610) (← links)
• Evaluation of Preoperative and Postoperative S100β and NSE Levels in Liver Transplantation and Right Lobe Living-Donor Hepatectomy: A Prospective Cohort Study (Q96813707) (← links)